​[[{“value”:”Terrain Bio Inks Secures Headquarters Lease in Cambridge Innovation Corridor

**Terrain Bio Leases New Headquarters at GENESIS 640 Memorial Drive in Cambridge**

Phase 3 Real Estate Partners, Inc. has announced that Terrain Bio, a cutting-edge biotech company that utilizes artificial intelligence, automated cell biology, and large-scale biobanks to revolutionize drug discovery, has signed a lease for its new headquarters at GENESIS 640 Memorial Drive. The property is situated within Cambridge’s vibrant innovation corridor. Specific terms of the lease were not disclosed.

The announcement comes as Phase 3 successfully delivers the final move-in-ready lab suites at GENESIS 640 Memorial Drive, further solidifying the property’s role as a key destination for life science innovation.

“Terrain Bio represents the kind of pioneering science that thrives in the Cambridge ecosystem,” said Morgan Weinstein, Vice President at Phase 3 Real Estate Partners. “Their decision to establish their headquarters at GENESIS 640 Memorial Drive reinforces not only the vitality of this market but also our broader commitment to delivering flexible, high-performance lab space across the GENESIS portfolio.”

CBRE acted as the leasing representative for Phase 3 Real Estate Partners, while Colliers provided tenant representation for Terrain Bio.

“}]]